GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Bruker Biosciences Corporation (BRKR) [hlAlert]

Rating:
Buy BRKR
up 38.43 %

Bruker Biosciences Corporation (BRKR) rated Buy with price target $16 by Brean Murray

Posted on: Friday,  Jun 25, 2010  8:25 AM ET by Brean Murray

Brean Murray rated Buy Bruker Biosciences Corporation (NASDAQ: BRKR) on 06/25/2010. Previously Brean Murray rated Buy Bruker Biosciences Corporation (NASDAQ: BRKR) on
03/03/2010., when the stock price was $13.53. Since then, Bruker Biosciences Corporation has gained 38.43% as of 01/28/2016's recent price of $18.73.
If you would have followed the previous Brean Murray's recommendation on BRKR, you would have gained 38.43% of your investment in 2157 days.

Bruker Corporation designs, manufactures, markets and services life science and materials research systems and associated products to address the needs of its customers in life science research and pharmaceutical, biotechnology and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. Its core technology platforms include X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies. It also manufactures and distributes a range of field analytical systems for chemical, biological, radiological and nuclear (CBRN), detection, as well as superconducting wire products and devices. It operates in four divisions: Bruker AXS, Bruker Daltonics, Bruker Optics and Bruker BioSpin.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/25/2010 8:25 AM Buy
None
13.27 16.00
as of 12/31/2010
1 Week up  0.41 %
1 Month up  10.63 %
3 Months up  21.59 %
1 YTD up  28.56 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2010 8:25 AM Buy
None
13.53 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy